SCHEDULE 13G/A: Bleichroeder Entities Disclose 15% Passive Stake in MDxHealth SA

Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach have jointly disclosed a 15% beneficial ownership stake in MDxHealth SA, holding 7,429,609 ordinary shares.

Summary

• Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach are the reporting persons for this Schedule 13G filing.
• The filing pertains to Ordinary Shares of MDxHealth SA (CUSIP: 58286E102).
• The reporting persons collectively beneficially own 7,429,609 ordinary shares of MDxHealth SA.
• This ownership represents 15% of the 49,497,334 ordinary shares reported by MDxHealth SA as outstanding.
• The reporting persons hold sole voting and sole dispositive power over all 7,429,609 shares.
• A significant portion of these shares, specifically 4,014,216 shares (8.11% of outstanding Common Stock), are held by 21 April Fund Ltd., for which Bleichroeder LP acts as investment adviser.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of MDxHealth SA.

Sentiment

Score: 5

Explanation: The document is a factual, routine regulatory filing disclosing beneficial ownership, with no inherent positive or negative sentiment regarding the issuer's performance or outlook.

Positives

• The document, being a Schedule 13G filing, primarily serves as a disclosure of beneficial ownership and does not contain specific positive operational or financial performance details for MDxHealth SA.

Negatives

• The document, being a Schedule 13G filing, primarily serves as a disclosure of beneficial ownership and does not contain specific negative operational or financial performance details for MDxHealth SA.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not provide any forward-looking statements or guidance regarding MDxHealth SA's future performance or strategic outlook.

Management Comments

• The reporting persons (Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach) certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of MDxHealth SA.

Industry Context

This document is a regulatory filing disclosing an ownership stake in MDxHealth SA, a company operating in the healthcare diagnostics sector. The filing itself does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• This document is a standard Schedule 13G filing, which is a routine disclosure for passive investors acquiring more than 5% of a company's shares. It does not contain information for comparison to industry-specific operational or financial benchmarks.

Related Party Transactions

• 21 April Fund Ltd., a Cayman Islands company for which Bleichroeder LP acts as investment adviser, holds 4,014,216 shares (8.11%) of the total 7,429,609 shares beneficially owned by the reporting persons.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant passive ownership stake by institutional investors, which can be viewed as a vote of confidence or simply a routine investment.

Next Steps

• Future amendments to this Schedule 13G will be filed if there are material changes to the beneficial ownership stake of the reporting persons in MDxHealth SA.

Key Dates

Keywords

MDxHealth SA, Bleichroeder LP, Bleichroeder Holdings LLC, Andrew Gundlach, Schedule 13G, beneficial ownership, ordinary shares, investment adviser, healthcare diagnostics